REFRACTORY HAIRY CELL LEUKEMIA
Clinical trials for REFRACTORY HAIRY CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY HAIRY CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY HAIRY CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. The approach uses low-dose chemo and radiation before a donor stem cell infusion, followed by drugs to prevent graft-versus-host disease. The goal was to control the cancer…
Matched conditions: REFRACTORY HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 11:19 UTC
-
New antibody drug shows promise for tough blood cancers
Disease control CompletedThis early-stage trial tested a drug called flotetuzumab in 13 people with advanced blood cancers that had returned or stopped responding to treatment. The goal was to find the best dose and check for side effects. Flotetuzumab is a lab-made antibody that may stop cancer cells fr…
Matched conditions: REFRACTORY HAIRY CELL LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 14:01 UTC